miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma

Published:2017-04-27 Issue:17 Volume:129 Page:2408-2419
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Bartolomé-Izquierdo Nahikari¹,de Yébenes Virginia G.¹^ORCID,Álvarez-Prado Angel F.¹^ORCID,Mur Sonia M.¹,Lopez del Olmo Juan A.²^ORCID,Roa Sergio³^ORCID,Vazquez Jesus²⁴^ORCID,Ramiro Almudena R.¹^ORCID

Affiliation:

1. B Cell Biology Laboratory and

2. Cardiovascular Proteomics Laboratory, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain;

3. Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain; and

4. CIBER de Enfermedades Cardiovasculares, Madrid, Spain

Abstract

Key Points miR-28 is a regulator of the GC reaction that dampens B-cell receptor signaling and impairs B-cell proliferation and survival. miR-28 has antitumoral activity in BL and DLBCL.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/17/2408/1400156/blood731166.pdf

Reference51 articles.

1. Pathogenesis of human B cell lymphomas;Shaffer;Annu Rev Immunol,2012

2. Diffuse large B-cell lymphoma-treatment approaches in the molecular era;Roschewski;Nat Rev Clin Oncol,2014

3. Germinal centers;Victora;Annu Rev Immunol,2012

4. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme;Muramatsu;Cell,2000

5. Molecular mechanisms of antibody somatic hypermutation;Di Noia;Annu Rev Biochem,2007

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncoding RNAs in B cell non-Hodgkins lymphoma;Gene;2024-07

2. MicroRNA expression signature as a biomarker in the diagnosis of nodal T-cell lymphomas;Cancer Cell International;2024-01-30

3. miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication;Cell Death & Disease;2023-10-18

4. EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma;Viruses;2023-08-25

5. The importance of hsa-miR-28 in human malignancies;Biomedicine & Pharmacotherapy;2023-05